FIREBRICK PHARMA LIMITED

Firebrick Pharma was founded by Peter Molloy and Stephen Goodall (picture) in 2012 with the mission to develop a nasal spray based on povidone-iodine (PVP-I) for use as a treatment for the common cold... Firebrick Pharma is an Australian pharmaceutical innovator founded in 2012 with the mission to develop novel formulations for use in the nose.

Also known as: Firebrick Pharma, firebrickpharma.com

Primary location: Melbourne